News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) And Nicaragua Unveil New Rotavirus Vaccine Demonstration Project At Clinton Global Initiative; Merck & Co., Inc. (MRK) Will Provide Free Rotavirus Vaccine For All Infants Born In Nicaragua Over The Next Three Years, A $75 Million Commitment



9/22/2006 10:43:20 AM

NEW YORK--(BUSINESS WIRE)--Sept. 22, 2006--Merck & Co., Inc. and the Nicaraguan Ministry of Health today announced plans to conduct a joint project aimed to demonstrate the public health impact of implementing a full rotavirus vaccination program in Nicaragua. Through this project, all infants born in Nicaragua in a three-year period will receive free doses of ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent), Merck's oral, ready-to-use vaccine to prevent rotavirus gastroenteritis in infants and young children when given in a three-dose series to infants between the ages of six to 32 weeks. In addition to providing ROTATEQ, Merck will also provide technical assistance for the duration of the program.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES